A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.

Clinical Trial ID NCT05025787

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT05025787

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 121.58
2 Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988 35.68
3 Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975 18.25
4 Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005 11.80
5 Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007 9.05
6 Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008 7.21
7 Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 2004 3.57
8 Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 2010 3.24
9 An application of a mixed-effects location scale model for analysis of Ecological Momentary Assessment (EMA) data. Biometrics 2007 1.77
10 Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain 2007 1.70
11 Development of short forms from the PROMIS™ sleep disturbance and Sleep-Related Impairment item banks. Behav Sleep Med 2011 1.45
12 Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol 1997 1.42
13 The Hospital Anxiety and Depression Scale: a meta confirmatory factor analysis. J Psychosom Res 2012 1.40
14 Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee. Osteoarthritis Cartilage 2003 1.29
15 Immediate antecedents of marijuana use: an analysis from ecological momentary assessment. J Behav Ther Exp Psychiatry 2011 1.20
16 Modeling between-subject and within-subject variances in ecological momentary assessment data using mixed-effects location scale models. Stat Med 2012 1.15
17 Targeting chemokine receptors in chronic inflammatory diseases: an extensive review. Pharmacol Ther 2011 1.13
18 Chemokine signaling and the management of neuropathic pain. Mol Interv 2009 1.07
19 Associations between daily chronic pain intensity, daily anger expression, and trait anger expressiveness: an ecological momentary assessment study. Pain 2012 1.00
20 Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION study. Pain 2014 0.97
21 Osteoarthritic pain: a review of current, theoretical and emerging therapeutics. Expert Opin Investig Drugs 2008 0.93
22 Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement. Osteoarthritis Cartilage 2015 0.93
23 A three-level mixed-effects location scale model with an application to ecological momentary assessment data. Stat Med 2012 0.89
24 Ecological momentary assessment for chronic pain in fibromyalgia using a smartphone: a randomized crossover study. Eur J Pain 2013 0.86
25 Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry 2015 0.85
26 A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia. Pain 2013 0.83
27 Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain 2016 0.81
28 Validity of PROMIS physical function measured in diverse clinical samples. J Clin Epidemiol 2016 0.81
29 Quantitative testing in spinal cord injury: overview of reliability and predictive validity. J Neurosurg Spine 2012 0.80
30 A comparison of four methods for the analysis of N-of-1 trials. PLoS One 2014 0.78
31 Chronobiology of chronic pain: focus on diurnal rhythmicity of neuropathic pain. Curr Opin Support Palliat Care 2014 0.78
32 Ecological Momentary Assessment in Physical Activity Research. Exerc Sport Sci Rev 2016 0.76
33 Development and evaluation of short forms of the Pain Catastrophizing Scale and the Pain Self-efficacy Questionnaire. Eur J Pain 2015 0.76
34 Celecoxib for osteoarthritis. Cochrane Database Syst Rev 2017 0.75
35 Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care. J Gen Intern Med 2017 0.75
Next 100